Human Papillomavirus (HPV) Testing - Cervical Cancer Screening

Human papillomavirus (HPV) is the most common sexually transmitted viral infection and is the etiologic agent for most cases of cervical cancer. High-risk HPV genotypes are also associated with an increased risk of developing vulvar, vaginal, anal, penile, and oropharyngeal cancer. Most cases of HPV clear within 1-2 years.  The American Cancer Society (ACS), American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) jointly recommend an age-based approach to cervical cancer screening. Testing options vary depending on the woman’s age, but include cytology, cotesting, and primary high-risk HPV (hrHPV) testing. There is no routinely recommended screening test for other HPV-related cancers.

Tabs Content
Content Review: 
February 2019

Last Update: November 2019